Early research (Phase 1)Study completedNCT03042793What this trial is testingVaccination With PD-L1 Peptide Against Multiple MyelomaWho this might be right forMultiple Myeloma Lene Meldgaard Knudsen 10
Large-scale testing (Phase 3)Study completedNCT02420821What this trial is testingAtezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC)Who this might be right forRenal Cell Carcinoma Hoffmann-La Roche 915
Testing effectiveness (Phase 2)WithdrawnNCT06557278What this trial is testingCombined AlloStim+Anti-PD-L1 in 4L MSS Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Mirror Biologics, Inc.
Large-scale testing (Phase 3)Study completedNCT02813785What this trial is testingAtezolizumab Compared With Docetaxel in Non-Small Cell Lung Cancer (NSCLC) After Failure With Platinum-Containing ChemotherapyWho this might be right forCarcinoma, Non-Small-Cell Lung Hoffmann-La Roche 565
Testing effectiveness (Phase 2)Looking for participantsNCT05769725What this trial is testingEvaluate Serplulimab in Combination With Docetaxel +S-1 VS. Docetaxel +S-1 as Adjuvant Treatment Therapy in Stage IIIc Gastric CancerWho this might be right forSerplulimab,Gastric Cancer, Adjuvant Therapy RenJi Hospital 70
Large-scale testing (Phase 3)Active Not RecruitingNCT04380636What this trial is testingStudy of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)Who this might be right forLung NeoplasmsCarcinoma, Non-Small-Cell Lung Merck Sharp & Dohme LLC 870
Not applicableStudy completedNCT04879316What this trial is testingEnergy for LymphocytesWho this might be right forNon-small Cell Lung CancerProgression, Disease Hôpital Cochin 144
Testing effectiveness (Phase 2)Ended earlyNCT03382899What this trial is testingStudy of Pegilodecakin (LY3500518) With Pembrolizumab Compared to Pembrolizumab Alone First-line Tx in Participants With Metastatic Non-Small Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer Eli Lilly and Company 101
Testing effectiveness (Phase 2)Looking for participantsNCT07176312What this trial is testingZanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) PatientsWho this might be right forGastroesophageal AdenocarcinomaFirst Line TherapyHER2 + Gastric Cancer+2 more Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 80
Testing effectiveness (Phase 2)Study completedNCT02031458What this trial is testingAtezolizumab in Participants With Programmed Death - Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Hoffmann-La Roche 667
Testing effectiveness (Phase 2)Study completedNCT04115111What this trial is testingDiadem to Investigate the Activity and Safety of DurvalumabWho this might be right forPleura Mesothelioma Mario Negri Institute for Pharmacological Research 57
Testing effectiveness (Phase 2)Active Not RecruitingNCT05012371What this trial is testingLenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell CancerWho this might be right forAdvanced Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more M.D. Anderson Cancer Center 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05280626What this trial is testingFirst-line Treatment of P53 Mutation With PD-L1 Expression in DLBCL With Anti-PD-1 Mab and R-CHOPWho this might be right forDiffuse Large B-Cell Lymphoma Innovent Biologics (Suzhou) Co. Ltd. 100
Testing effectiveness (Phase 2)UnknownNCT03961698What this trial is testingEvaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell CarcinomaWho this might be right forBreast CancerRenal Cell Carcinoma Infinity Pharmaceuticals, Inc. 91
Testing effectiveness (Phase 2)Looking for participantsNCT07169552What this trial is testingHC010 in First-line PD-L1 Positive Advanced NSCLC PatientsWho this might be right forNSCLC HC Biopharma Inc. 50
Testing effectiveness (Phase 2)Looking for participantsNCT06892548What this trial is testingA Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung CancerWho this might be right forAdvanced Lung Cancer BioNTech SE 594
Early research (Phase 1)Study completedNCT04242238What this trial is testingStudy of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic SarcomasWho this might be right forSarcomaAdvanced SarcomaHigh Grade Sarcoma+4 more Memorial Sloan Kettering Cancer Center 32
Testing effectiveness (Phase 2)Looking for participantsNCT04951947What this trial is testingJS-201 Combined With Lenvatinib in the Treatment of Small-cell Lung CancerWho this might be right forSmall-cell Lung Cancer Hunan Province Tumor Hospital 30
Early research (Phase 1)Looking for participantsNCT06066138What this trial is testingTherapeutic Drug Monitoring-Based Atezolizumab DosingWho this might be right forLocally Advanced Alveolar Soft Part SarcomaMetastatic Alveolar Soft Part SarcomaLocally Advanced Non Small Cell Lung Cancer+7 more National Cancer Institute (NCI) 30
Not applicableUnknownNCT05228808What this trial is testingImmunohistochemical Expression of PD-L1 in Pancreatic Ductal AdenocarcinomaWho this might be right forPancreatic Adenocarcinoma Sohag University 50